Desmoid Tumor of lung with pleural involvement : the case of unique location of aggressive fibromatosis by Tokarek, Tomasz et al.
Desmoid tumor of lung with pleural involvement —  
the case of unique location of aggressive fibromatosis
Tomasz Tokarek1, Joanna Szpor1, Juliusz Pankowski2, Krzysztof Okoń1
1Department of Pathomorphology Jagiellonian University Medical College 
ul. Grzegórzecka 16, 31-531 Kraków, Poland
2Sokolowski Pulmonary Hospital in Zakopane 
ul. Gładkie 1, 34-500 Zakopane, Poland
Corresponding author: Tomasz Tokarek, Department of Pathology, Jagiellonian University Medical College 
ul. Grzegórzecka 16, 31-531 Kraków, Poland; Phone: +48 12 421 15 64; Email: tomek.tokarek@gmail.com
Abstract: Desmoid tumors (DTs) are rare mesenchymal neoplasms with unpredictable natural history. There is a high risk 
of recurrence despite adequate surgical resection, however DTs do not have the capacity to metastasize. The estimated 
incidence in general population is 2–4 cases/million/year. They may occur at any age but most commonly in the third and 
fourth decades. Both sexes may be affected, but there is a slight female predominance. DTs can occur at any body site. The 
exact etiology remains unclear, but trauma, hormonal disturbances, pregnancy, genetic and hereditary factors are postu-
lated to be in association with its’ development. Potential to attain large size, infiltration and destruction of adjacent vital 
structures and tendency to recur are main management problems and important causes of morbidity and mortality. Wide 
excision is standard first-line treatment of primary or recurrent symptomatic desmoids. We present case of 33-years-old 
Caucasian female patient admitted to hospital with 2 months history of squeezing pain in right upper quadrant which 
appeared after meals. The patient was in general good condition. There were no abnormalities on basic laboratory tests 
on admission. CT of chest revealed hydrothorax to the level of the apex of the right lung and tumor sized 7 × 13 × 13 cm 
located in the lower lobe of right lung. Histopathological diagnosis of desmoid tumor of right lung was formulated. We 
report, to our knowledge for the first time in Poland, case of aggressive fibromatosis of lung with invasion of pleura.
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Introduction
Desmoid tumors (DTs), also called deep or aggressive fibromatosis, are rare mesenchymal 
neoplasms with unpredictable natural history. DTs arise from fascial and muscle-aponeurotic 
structures and are composed of proliferating spindle cells arranged in long fascicles. DTs have 
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high risk of recurrence (25–65%) [1], despite adequate surgical resection, but do not have the 
capacity to metastasize. They account for 0.03% of all neoplasms2. The estimated incidence 
in general population is 2–4 cases per million per year, there is no significant racial or ethnic 
predilection [2]. DTs may occur at any age but the most commonly in the third and fourth 
decades [3]. Both sexes may be affected, but there is a slight female predominance [3]. DTs 
can occur at any body site, but the abdominal wall, soft tissue of the extremities, shoulder, 
neck and chest wall are the most frequent location [2]. Symptoms are depending on location. 
Patient usually presents with a slow growing firm mass greater than 5cm without associated 
pain or discomfort, unless there is nerve involvement. The exact etiology of DTs remains 
unclear, but trauma, hormonal disturbances, pregnancy, genetic and hereditary factors are 
postulated to be in association with DTs development [3, 4].
Case report
33-years-old Caucasian female patient was admitted to the Sokolowski Pulmonary Hospi-
tal in Zakopane with 2 months history of squeezing pain in right upper quadrant which 
appeared after meals. She was in good general condition, suffered of hypothyreosis but had 
no other chronic diseases. Her body weight was stable in the last few months. The patient 
underwent 2 birth, last period was 2 years before symptoms of the current disease began. 
She was permanently on letrox and oral contaception (depot medroxyprogesterone acetate). 
Family history was not contributory. There were no abnormalities on basic laboratory tests 
on admission. CT revealed hydrothorax to the level of the apex of the right lung and tumor 
sized 7 × 13 × 13 cm located in the lower lobe of right lung (Fig. 1). Invasion of the 9th right 
Fig. 1. CT scan of thorax (frontal section). Hydrothorax to the level of the apex of the right lung and tumor 
in size of 7 × 13 × 13 cm in lower lobe of right lung, atelectasis of lower lobe of right lung.
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rib, thoracic vertebra 8th–9th and atelectasis of lower lobe of right lung were observed. Fine 
needle aspiration biopsy performed during bronchoscopy revealed no diagnostic material. 
An exploratory right thoracotomy showed large tumor of lung deriving from lower posterior 
mediastinum. Incision biopsy was performed. Intraoperative histologic consultation con-
firmed involvement of pleura by a tumor. Due to size of the tumor, involvement of pleura, 
infiltration of corpse of 8th–9th thoracic vertebra and 9th right rib and technical difficulty of 
surgery combined with expected poor postoperative outcome the resection of the tumor 
was not performed. Obtained samples were evaluated, in correspondence with clinical pre-
sentation, histopathological diagnosis of desmoid tumor of right lung with involvement of 
the pleura was formulated. Postoperative course was uneventful. The patient was discharged 
from hospital in good general conditions instructed of further treatment but failed to present 
herself to next appointment and was lost from follow up.
Material and methods 
Clinical data was obtained from the archive files of Sokolowski Pulmonary Hospital in Zako-
pane. The original samples had been fixed in the formaldehyde solution, routinely processed 
and embedded in paraffin and stained with haematoxylin and eosin. Immunohistochemistry 
was performed using a standard protocol. 
Pathological examination
Histologically the tumor was composed of spindle cells, arranged in short, partially ir-
regular fascicles (Fig. 2, Fig 3). The stroma contained myxoid foci, collagen clusters and 
Fig. 2. Spindle-shaped cells with fascicular architecturem thick collagen fibres, dense collagen in area 
(Gomori trichrome stain, original magnification × 40)
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hemorrhagic areas. Vessels were surrounded by distinct myopericit cuff. The cells showed 
neither polymorphism nor mitotic activity. Some plasma cells, mast cells and lymphocytes 
were seen within the tumor. Tumor cells showed expression of smooth muscle actin (SMA) 
and beta-catenin, the later both in cytoplasmatic and nuclear location, but was negative for 
CD34, desmin, S-100, ALK1, HHV8, calretinin, pan-cytokeratin (pan-CK), CK5/6, EMA 
and HMB45. Proliferation activity of neoplastic cells as measured by expression of anti-
gen Ki 67 was low (<2%). These findings were consistent with the diagnosis of desmoid 
tumor.
Discussion
Aggressive fibromatoses can be classified as extra-abdominal (60%), abdominal (25%) and in-
tra-abdominal (15%) [5]. DTs of the chest represent 20% of all extra-abdominal fibromatoses [5]. 
Only 37 cases of intra-thoracic DTs have been reported in the English-language literature [5]. 
The majority were apparently originating from the chest wall with major intra-thoracic 
extensions [5]. True primary intrapleural desmoid tumors are extremely rare, with only 
12 reported cases [5]. The age of the patients in the reported intra-thoracic DTs cases ranged 
from 2.5 to 73 years (mean 32.3 years) [5]. Twenty-two patients were men and 15 patients were 
women, which differs from the common female predominance of extra-abdominal desmoids [5]. 
Most of intra-thoracic DTs (60%) were greater than 10 cm at the time of diagnosis [5]. 
True intra-thoracic DTs are generally asymptomatic until the tumour becomes to large, with 
compression of the surrounding organs [5]. Most of the reported (95%) intra-thoracic cases 
were treated with surgical resection. The radicality of the surgical resection is reported in only 
23 cases: microscopically negative (R0) in 9 cases (39%) and microscopically positive (R1) 
Fig. 3. Spindle-shaped neoplasm arranged in short, partially irregular fascicles (HE, original magnifica- 
tion × 40)
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in 6 cases (26%). Macroscopical residual tumour was left behind (R2) in 8 cases (35%) [5]. 
Adjuvant therapy was not reported in 19 of the reported intra-thoracic cases [5]. Radical 
resection may be difficult or impossible to perform if the tumor infiltrate paravertebral 
structures, the spine, the brachial plexus, great vessels, or extends into the soft tissues of 
the neck. Chest wall resections are characterized by a high rate of complications, ranging 
from 21% to 46% of cases [5]. Desmoid tumors may occur sporadically, in association with 
familial adenomatous polyposis (FAP; such association is referred as Gardner’s syndrome) 
or as hereditary desmoid disease [2]. DTs affects 10–15% of patients with FAP, and these 
patients have an over 800-fold increased risk of developing deep fibromatosis in comparison 
with general population [2]. Risk of DTs development in patients with FAP is associated with 
positive family history, female gender, an adenomatosis polyposis coli (APC) gene mutation 
3’ to codon 1399 and abdominal surgery in the past. Sporadic DTs are also associated with 
somatic mutations in either beta-catenin or APC genes [2]. 98% patients with sporadic DT 
were shown to have mutations of codons 41, 45 of exon 3 of beta-catenin gene (CTNNB1) [2]. 
Patients with mutations of codon 45 of exon 3 of beta-catenin gene (45F) are at particularly 
high risk for the recurrence [4]. Only 23% of patients with 45F mutations were free from 
progression at 5 years, while 59% of patients with a 41A mutations and 65% with no APC 
mutation had stable disease [2]. Both CTNNB1 and APC gene products are part of Wnt 
signaling pathway and mutations in either genes result in stabilization of beta-catenin pro-
tein leading to a constant activation of the T-cell factor/lymphoid enhancer factor (TCF/
Lef) family of transcription factors [4]. This signaling pathway may be a target for future 
therapies. Most studies have shown that DTs are negative for estrogen receptor (ER) alpha, 
progesteron receptor and c-kit, but positive for ER beta [2]. In fact, DTs grow is probably 
under hormonal control2. Length of telomers was found to be inversely related to the size 
of DTs [2]. Grossly, DT presents as a firm mass with poorly defined margins and adhering 
to adjacent structures. On histologic examination the lesion usually show infiltrative mar-
gins and consists of spindle-shaped cells arranged in broad sweeping fascicles separated 
by abundant collagen-rich stroma [4]. Tumor cells do not show cytological atypia and the 
mitotic activity is low. DTs express vimentin and SMA and usually do not show reactivity 
to desmin or S-100 protein. Molecular studies of X chromosome inactivation proved that 
these tumors are monoclonal proliferation, consistent with a neoplastic character rather 
than reactive process as thought in the past4. Potential to attain large size, infiltration of 
adjacent structures and tendency to recurrence are main management problems and im-
portant causes of complications and mortality. A multidisciplinary approach tailored to the 
individual case is required for good outcome. Asymptomatic or non-progressive tumors may 
be monitored without definitive treatment [4]. Spontaneous resolution may occur in some 
cases. Primary and recurrent DTs which are symptomatic, do progress or are located in the 
proximity of vital organs should be treated with surgical resection when broad margins are 
obtainable and risk of functional impairment and disfigurement is low. Radical surgery is 
not always feasible because of location and technical difficulty. Furthermore, DTs may re-
cur even after complete resection with seemingly negative margins. Further treatment may 
not be necessary even with positive resection margins. Recurrence is more frequent with 
extraabdominal (30–50%) than intraabdominal desmoids (15–30%) [3]. Positive surgical 
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margins are indications for adjuvant radiotherapy (RT) combined with surgery or definitive 
RT. Prominent or unacceptable function and cosmetic loss suggest to choose RT as first line 
treatment. The recommended dose of RT for definitive therapy is 50–60 Gy in 5-7 weeks 
at 1.8–2 Gy per fraction [2]. Local recurrence rates do not appear to be reduced by the use 
of higher doses [2]. Reasonable decision about using RT should balance between potential 
benefit and late side effects like secondary malignancies. Patients with unresectable DTs or 
multiple locoregional recurrences are candidates for systemic treatment. Possible options 
are: NSAIDs (e.g. sulindac, indomethacine), hormonal therapy (tamoxifen), interferon, cy-
totoxic agents (anthracyclines, liposomal pegylated doxorubicine), imatinib or new meth-
ods such as intralesional injections of irritating solutions and radiofrequency ablation. MRI 
allows to present exact relationship with adjacent structures therefore is the best option for 
imaging of desmoids. In addition MRI may have prognostic value because higher T2 sig-
nal is reportedly associated with more rapid growth [3]. After therapy it is recommended 
to perform imaging follow-up every 3–6 months and 6–12 weeks in patients undergoing 
chemoradiation3. Intervals between check-up depends on rate of growth and presence of 
symptoms. Recently, in a series of nine cases, FDG-PET was deemed reliable for the imaging 
of DTs and provided additional information in the response to imatinib, as exemplified by 
a decreased standardized uptake value of the tracer [2]. 
Conclusions
Because of difficulty of diagnosis, possibility to occur in any body site, variable clinical pre-
sentation and behavior, many cases might remain misdiagnosed and inadequately treated. 
Wide excision is standard first-line treatment of primary or recurrent symptomatic des-
moid. Radiological picture may be suggestive but an explicit confirmation of the diagno-
sis is based on histopathology. Intra-thoracic desmoids are exceedingly rare tumors, with 
37 reported cases in the English-language literature [5]. Involvement of the pleura is ex-
tremely rare for this entity, only 12 cases have been described [5]. We report, to our knowl-
edge for the first time in Poland, case of aggressive fibromatosis of lung with invasion of 
pleura.
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